EXHIBIT 31.1

      The following certification includes references to an evaluation of the
effectiveness of the design and operation of our "disclosure controls and
procedures" and to certain matters related to our "internal control over
financial reporting." Item 4 of Part II of this Quarterly Report presents the
conclusions of the CEO and the CFO about the effectiveness of our disclosure
controls and procedures based on and as of the date of such evaluation (relating
to Item 4 of the certification), and contains additional information concerning
disclosures to our Audit Committee and independent auditors with regard to
deficiencies in internal control over financial reporting and fraud and related
matters (Item 5 of the certification).

                                  CERTIFICATION

I, D. Michael Stout, M.D., certify that:

1. I have reviewed this quarterly report on Form 10-Q of UCI Medical Affiliates,
Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects,
the financial condition, results of operations and cash flows of the registrant
as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;

b) Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

c) Disclosed in this report any change in the registrant's internal control over
financial reporting that occurred during the registrant's most recent fiscal
quarter (the registrant's fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control over
financial reporting.


January 22, 2004              /s/ D.  Michael Stout, M.D.
                              ------------------------------
                              D.  Michael Stout, M.D.
                              President and Chief Executive Officer